RU2012158011A - METHOD AND COMPOSITION FOR TREATMENT OF CANCER - Google Patents
METHOD AND COMPOSITION FOR TREATMENT OF CANCER Download PDFInfo
- Publication number
- RU2012158011A RU2012158011A RU2012158011/15A RU2012158011A RU2012158011A RU 2012158011 A RU2012158011 A RU 2012158011A RU 2012158011/15 A RU2012158011/15 A RU 2012158011/15A RU 2012158011 A RU2012158011 A RU 2012158011A RU 2012158011 A RU2012158011 A RU 2012158011A
- Authority
- RU
- Russia
- Prior art keywords
- antivirulent
- types
- factors
- cancer
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract 3
- 201000011510 cancer Diseases 0.000 title claims abstract 3
- 241000894006 Bacteria Species 0.000 claims abstract 4
- 231100000433 cytotoxic Toxicity 0.000 claims abstract 4
- 230000001472 cytotoxic effect Effects 0.000 claims abstract 4
- 230000003013 cytotoxicity Effects 0.000 claims abstract 2
- 231100000135 cytotoxicity Toxicity 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Метод лечения или предупреждения рака, включающий в себя введение пациенту терапевтически эффективного количества одного или нескольких видов цитотоксических бактерий в комбинации с одним или несколькими видами антивирулентных факторов, где один или несколько антивирулентных факторов уменьшают или устраняют общую цитотоксичность одной или нескольких цитотоксических бактерий.A method of treating or preventing cancer, comprising administering to a patient a therapeutically effective amount of one or more types of cytotoxic bacteria in combination with one or more types of antivirulent factors, where one or more antivirulent factors reduce or eliminate the overall cytotoxicity of one or more cytotoxic bacteria.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012158011/15A RU2012158011A (en) | 2012-12-28 | 2012-12-28 | METHOD AND COMPOSITION FOR TREATMENT OF CANCER |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012158011/15A RU2012158011A (en) | 2012-12-28 | 2012-12-28 | METHOD AND COMPOSITION FOR TREATMENT OF CANCER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012158011A true RU2012158011A (en) | 2014-07-10 |
Family
ID=51215635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012158011/15A RU2012158011A (en) | 2012-12-28 | 2012-12-28 | METHOD AND COMPOSITION FOR TREATMENT OF CANCER |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2012158011A (en) |
-
2012
- 2012-12-28 RU RU2012158011/15A patent/RU2012158011A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA117451C2 (en) | Therapeutically active compounds and their methods of use | |
| SG10201808102WA (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| WO2016106403A3 (en) | Therapeutic compositions and methods for malignant tumors with rnai molecules targeted to hsp47 and p21 | |
| PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
| NZ630805A (en) | Pharmaceutical combinations comprising a thionucleotide analog | |
| MX2013012253A (en) | Novel binder-drug conjugates (adcs) and their use. | |
| MX2017017138A (en) | Targeted conjugates of ksp inhibitors. | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
| MX367926B (en) | Pharmaceutical composition for a sustained release of lanreotide. | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| NZ707636A (en) | Ingenol-derived compounds that can be used for treating cancer | |
| TW201129361A (en) | Methods for treating pain | |
| MX2015005733A (en) | Tricyclic compounds for use in the treatment and/or control of obesity. | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| MX2014014814A (en) | Pharmaceutical composition for treating inflammation and pain. | |
| MX2021014120A (en) | Treatment of androgen deprivation therapy associated symptoms. | |
| MX2017013666A (en) | Anti-fugetactic agent and immunotherapy agent combination therapy and compositions for the treatment of cancer. | |
| GB201115977D0 (en) | Neurodevelopmental disorders | |
| RU2012158011A (en) | METHOD AND COMPOSITION FOR TREATMENT OF CANCER | |
| EA201491836A1 (en) | METHODS OF CANCER TREATMENT USING PI3K INHIBITOR AND MEK INHIBITOR | |
| MX2021001081A (en) | Combination therapy for treating cancer. | |
| MX2018015240A (en) | Compositions comprising timolol and their use in the treatment of rosacea by topical administration. | |
| NZ631362A (en) | Arry-520 for use in treating cancer in a patient with low aag |